Internal Medicine · Lafayette, LA
NPI
1821052754
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2930 Moss St, Suite B
Lafayette, LA, 70501
Phone (337) 261-0559
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,890 services
Medicare patients, 2024
449
Average age 71
Drug cost, 2024
$2.3M
11,640 prescriptions
Company payments, 2025
$2,858
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryan A Lebean Sr. was code 99214 (office e&m - established), 334 times for 190 patients. In total Bryan A Lebean Sr. billed 1,890 services in 31 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 334 | 190 | $80.43 | $27K |
| 99213 Office E&M - Established | Office | 292 | 198 | $58.81 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 235 | 114 | $11.35 | $2,667 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 190 | 42 | $32.09 | $6,097 |
| 99204 Office E&M - New | Office | 157 | 156 | $113.52 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 145 | 145 | $119.77 | $17K |
| 99458 E&M - Miscellaneous | Office | 122 | 36 | $20.85 | $2,543 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 96 | 43 | $39.18 | $3,761 |
| 99457 E&M - Miscellaneous | Office | 70 | 37 | $25.83 | $1,808 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 58 | 27 | $29.92 | $1,735 |
| 97750 Occupational Therapy | Office | 36 | 12 | $10.24 | $369 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 22 | 21 | $188.65 | $4,150 |
| 99484 Behavioral Health Services | Office | 20 | 11 | $32.96 | $659 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 18 | 18 | $43.52 | $783 |
By year: 2022 $209K for 3,863 services; 2023 $143K for 3,064 services; 2024 $110K for 1,890 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bryan A Lebean Sr. prescribed most often to Medicare patients was Amlodipine Besylate, with 603 prescriptions and refills. In total Bryan A Lebean Sr. wrote 11,640 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 603 | 1,396 | 158 | $3,504 |
| Rosuvastatin Calcium Generic | 437 | 1,051 | 121 | $4,850 |
| Pantoprazole Sodium Generic | 405 | 869 | 102 | $4,048 |
| Ozempic Semaglutide | 379 | 501 | 61 | $477K |
| Alprazolam Generic | 333 | 363 | 53 | $1,562 |
| Eszopiclone Generic | 310 | 363 | 64 | $5,965 |
| Olmesartan Medoxomil Generic | 255 | 535 | 72 | $3,629 |
| Carvedilol Generic | 247 | 587 | 64 | $2,315 |
| Irbesartan Generic | 228 | 506 | 60 | $3,895 |
| Meloxicam Generic | 217 | 495 | 62 | $986 |
| Fluticasone Propionate Generic | 209 | 386 | 82 | $2,950 |
| Pregabalin Generic | 194 | 294 | 47 | $6,406 |
| Atorvastatin Calcium Generic | 185 | 361 | 44 | $1,665 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 184 | 221 | 52 | $5,841 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 181 | 413 | 42 | $5,002 |
Brand drugs: 2,437 claims; generic drugs: 9,098 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan A Lebean Sr. $2,858 ($2,858 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $386.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $386 |
| Coloplast Corp | 2 | $342 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $289 |
| Ardelyx, Inc. ARDX | 15 | $236 |
| Axsome Therapeutics, Inc. AXSM | 6 | $177 |
| Harmony Biosciences LLC HRMY | 7 | $163 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $144 |
| GlaxoSmithKline, LLC. GSK | 7 | $133 |
| Stryker Corporation SYK | 1 | $129 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.